Fludarabine and pancytopenia Patient Reports February 12, 2012

Fludarabine Side Effects Report #5643303-5
Fludarabine side effect was reported by a Health Professional from ITALY on Feb 12, 2008. Male patient, 24 years of age, was diagnosed with t-cell type acute leukaemia, antifungal prophylaxis and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: alternaria infection, pancytopenia. Fludarabine dosage: unknown. During the same period patient was treated with CYTARABINE, IDARUBICIN, NEUPOGEN, ITRACONAZOLE. Patient recovered.

Fludarabine Side Effects Report #5645798-X
Fludarabine side effect was reported by a Health Professional from ITALY on Feb 12, 2008. Male patient, 24 years of age, was diagnosed with t-cell type acute leukaemia, antifungal prophylaxis and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: alternaria infection, pancytopenia. Fludarabine dosage: unknown. During the same period patient was treated with CYTARABINE, IDARUBICIN, NEUPOGEN, ITRACONAZOLE. Patient recovered.

Fludarabine Side Effects Report #4810873-6
Fludarabine side effect was reported by a Health Professional from UNITED STATES on Oct 25, 2005. Male patient, weighting 176.6 lb, was diagnosed with stem cell transplant and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood bilirubin increased, hepatosplenomegaly, pancytopenia, venoocclusive disease, weight increased. Fludarabine dosage: 48MG DAILY IV DRIP. During the same period patient was treated with BUSULFAN, CAMPATH. Patient died on 10/21/2005.

Fludarabine Side Effects Report #4563113-X
Fludarabine side effect was reported by a Health Professional from on Jan 12, 2005. Male patient, 66 years of age, weighting 158.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, chromosome abnormality, haematuria, herpes zoster, hydronephrosis, myelodysplastic syndrome, pancytopenia, pleural effusion. Fludarabine dosage: 70 MG, CYCLE X 5D, ORAL. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, HALCION, NIZORAL, PURSENNID, SULFAMETHOXAZOLE, FUNGIZONE, ISODINE GARGLE. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #4577993-5
Fludarabine side effect was reported by a Health Professional from on Feb 02, 2005. Male patient, 66 years of age, weighting 158.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, bone marrow depression, chromosome abnormality, herpes zoster, hydronephrosis, myelodysplastic syndrome, pancytopenia, pleural effusion. Fludarabine dosage: 70 MG, CYCLE X 5D, ORAL. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, HALCION, NIZORAL, PURSENNID, SULFAMETHOXAZOLE. Patient was hospitalized. Patient died.

Fludarabine Side Effects Report #4590326-3
Fludarabine side effect was reported by a Health Professional from on Feb 08, 2005. Male patient, 66 years of age, weighting 158.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression, haematuria, herpes zoster, hydronephrosis, myelodysplastic syndrome, pancytopenia, pleural effusion. Fludarabine dosage: 70 MG, CYCLE X 5D, ORAL. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, HALCION, NIZORAL, PURSENNID, SULFAMETHOXAZOLE. Patient was hospitalized. Patient died on 01/22/2005.

Fludarabine Side Effects Report #4830028-9
Fludarabine side effect was reported by a Pharmacist from UNITED STATES on Nov 15, 2005. Male patient, 58 years of age, weighting 211.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, feeling abnormal, hyperhidrosis, non-hodgkin's lymphoma recurrent, pancytopenia, thrombocytopenia. Fludarabine dosage: 55MG IV X 5 DAYS. During the same period patient was treated with RITUXIMAB, PROCHLORPERAZINE, ONDANSETRON, SENNA, VITAMINS. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #4907304-4
Fludarabine side effect was reported by a Pharmacist from UNITED STATES on Feb 08, 2006. Male patient, 58 years of age, weighting 212.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: body temperature increased, fatigue, oedema peripheral, pancytopenia, productive cough. Fludarabine dosage: 55 MG IV DAILY X 5 DAYS. During the same period patient was treated with RITUXIMAB, SENNA, PROCHLORPERAZINE, FILGRASTIM. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #5723832-6
Fludarabine side effect was reported by a Health Professional from UNITED STATES on Apr 29, 2008. Male patient, weighting 143.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: bone marrow disorder, cardiac tamponade, continuous haemodiafiltration, hypotension, pancytopenia, pericardial effusion, pulmonary oedema, pyrexia, renal failure. Fludarabine dosage: 30MG/M2 DAILY IV DRIP. During the same period patient was treated with THIOTEPA, TOTAL BODY IRRADIATION, RABBIT ATG. Patient died on 04/26/2008.

Fludarabine Side Effects Report #4941416-4
Fludarabine side effect was reported by a Health Professional from IRELAND on Feb 24, 2006. Male patient, 70 years of age, weighting 145.5 lb, was diagnosed with chronic lymphocytic leukaemia refractory and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: bone marrow failure, intestinal perforation, pancytopenia, pulmonary tuberculosis. Fludarabine dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, NEUPOGEN, PLATELETS. Patient was hospitalized and became disabled. Patient died on 11/04/2005.

Fludarabine Side Effects Report #6083624-8
Fludarabine side effect was reported by a Physician from NETHERLANDS on Feb 12, 2009. Female patient, 72 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: bone marrow tumour cell infiltration, cerebrovascular accident, chronic lymphocytic leukaemia, pancytopenia. Fludarabine dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient died on 12/25/2007.

Fludarabine Side Effects Report #6094522-8
Fludarabine side effect was reported by a Physician from NETHERLANDS on Feb 12, 2009. Female patient, 72 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: bone marrow tumour cell infiltration, cerebrovascular accident, disease progression, pancytopenia. Fludarabine dosage: 40 MG/M2, ORAL. During the same period patient was treated with CYCLOPHOSPHAMDE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient died.

Fludarabine Side Effects Report #5617251-0
Fludarabine side effect was reported by a Physician from UNITED STATES on July 11, 2007. Female patient, 70 years of age, weighting 132.3 lb, was diagnosed with chronic lymphocytic leukaemia, hypotension, thrombocytopenia, prophylaxis against gastrointestinal ulcer, anaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: bicytopenia, cardiovascular insufficiency, hepatitis

, mucosal inflammation, pancytopenia, skin exfoliation, thrombocytopenia. Fludarabine dosage: UNIT DOSE: 48 MG. During the same period patient was treated with MABCAMPATH, RINGER, ETHAMSYLATE, FAMOTIDINE, PLATELETS, RED BLOOD CELLS, METHYLPREDNISOLONE. Patient was hospitalized and became disabled. Patient died on 07/15/2006.

Fludarabine Side Effects Report #5444151-1
Fludarabine side effect was reported by a Pharmacist from UNITED STATES on Sept 04, 2007. Male patient, 68 years of age, weighting 243.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: blood culture positive, bone marrow failure, fungal infection

, hypoacusis, mental status changes, myalgia, pancytopenia, respiratory distress. Fludarabine dosage: 60MG QD X 3;Q28D IV. Patient was hospitalized. Patient died on 08/05/2007.

Fludarabine Side Effects Report #5615373-1
Fludarabine side effect was reported by a Physician from POLAND on Jan 30, 2008. Male patient, 64 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: cardiovascular insufficiency, lung infection, lymphadenopathy, opportunistic infection, pancytopenia, pyrexia, respiratory failure, tuberculosis test positive, urinary tract infection

. Fludarabine dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, CAMPATH. Patient was hospitalized and became disabled. Patient died on 08/18/2007.

Fludarabine Side Effects Report #5947977-0
Fludarabine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 27, 2008. Female patient, 74 years of age, was diagnosed with b-cell small lymphocytic lymphoma refractory, chronic lymphocytic leukaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: blood count abnormal, lymphopenia, no therapeutic response, pancytopenia. Fludarabine dosage: unknown. During the same period patient was treated with ALEMTUZUMAB, CYCLOPHOSPHAMIDE, ACYCLOVIR, CHLORAMBUCIL, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #5961587-0
Fludarabine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 04, 2008. Female patient, 74 years of age, was diagnosed with b-cell small lymphocytic lymphoma refractory, chronic lymphocytic leukaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: condition aggravated, lymphopenia, no therapeutic response, pancytopenia, thrombocytopenia. Fludarabine dosage: unknown. During the same period patient was treated with ALEMTUZUMAB, CYCLOPHOSPHAMIDE, ACYCLOVIR, CHLORAMBUCIL, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #5164927-8
Fludarabine side effect was reported by a Physician from AUSTRALIA on Nov 10, 2006. Female patient, 66 years of age, was diagnosed with b-cell lymphoma and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome, neutropenic sepsis, pancytopenia. Fludarabine dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB, MITOXANTRONE. Patient died.

Fludarabine Side Effects Report #5069810-4
Fludarabine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 13, 2006. Female patient, 16 years of age, was diagnosed with aplastic anaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: acute graft versus host disease in skin, anaemia haemolytic autoimmune, aplastic anaemia, bone marrow disorder, disease recurrence, pancytopenia, renal failure, viral infection

. Fludarabine dosage: unknown. During the same period patient was treated with CAMPATH, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CORTICOSTEROIDS. Patient recovered.

Fludarabine Side Effects Report #5247354-4
Fludarabine side effect was reported by a Health Professional from UNITED STATES on Feb 08, 2007. Female patient, 65 years of age, weighting 169.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: activities of daily living impaired, burning sensation, hyperaesthesia, pancytopenia, paraesthesia. Fludarabine dosage: 26 MG IVP QD X 5D IV. During the same period patient was treated with CARBOPLATIN, TOPOTECAN, THALIDOMIDE. Patient recovered.

Fludarabine Side Effects Report #4810015-7
Fludarabine side effect was reported by a Health Professional from UNITED STATES on Oct 24, 2005. Male patient, weighting 163.1 lb, was diagnosed with acute leukaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood bilirubin increased, hepatosplenomegaly, pancytopenia, venoocclusive disease, weight increased. Fludarabine dosage: 48 MG DAILY IV DRIP. During the same period patient was treated with BUSULFAN, CAMPATH. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #5279402-X
Fludarabine side effect was reported by a Health Professional from BULGARIA on Mar 19, 2007. Female patient, 69 years of age, weighting 132.3 lb, was diagnosed with chronic lymphocytic leukaemia, hypotension, thrombocytopenia, anaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: bicytopenia, cardiovascular insufficiency, hepatitis

, mucosal inflammation, pancytopenia, skin exfoliation, thrombocytopenia. Fludarabine dosage: 48 MG, 1X/DAY. During the same period patient was treated with MABCAMPATH, RINGER, ETHAMSYLATE, FAMOTIDINE, PLATELETS, RED BLOOD CELLS, METHYLPREDNISOLONE. Patient was hospitalized and became disabled. Patient died on 07/15/2006.

Fludarabine Side Effects Report #5522602-1
Fludarabine side effect was reported by a Health Professional from UNITED KINGDOM on Nov 12, 2007. Female patient, 67 years of age, was diagnosed with prophylaxis and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: cataract

, optic atrophy, pancytopenia, retinitis viral. Fludarabine dosage: unknown. During the same period patient was treated with CHLORAMBUCIL, PREDNISOLONE, PLATELETS. Patient recovered.

Fludarabine Side Effects Report #5468905-0
Fludarabine side effect was reported by a Health Professional from POLAND on Sept 21, 2007. Female patient, 63 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: cardiovascular insufficiency, chronic lymphocytic leukaemia, lung infection, lymphadenopathy, pancytopenia, pyrexia, respiratory failure, tuberculosis test positive. Fludarabine dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, CAMPATH. Patient was hospitalized and became disabled. Patient died on 08/18/2007.

Fludarabine and pancytopenia

SideEffects101.com

Fludarabine and pancytopenia Patient Reports February 12, 2012

side effects of Fludarabine